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WNTactor NKX2.5 plays a crucial role in cardiomyogenesis, but its mechanism of
regulation is still unclear. Recently, epigenetic regulation has become increasingly recognized as important in
differentiation and development. In this study, we used P19CL6 cells to investigate the regulation of Nkx2.5
expression by methylation and acetylation during cardiomyocyte differentiation. During the early stage of
differentiation, Nkx2.5 expression was upregulated, but the methylation status of the Nkx2.5 promoter did
not undergo signiﬁcant change; while the acetylation levels of histones H3 and H4 were increased,
accompanied by a signiﬁcant reduction in Hdac1 expression. Suppression of Hdac1 activity stimulated
cardiac differentiation accompanied by increased expression of cardiac-speciﬁc genes and cell cycle arrest.
Overexpression of Hdac1 inhibited cardiomyocyte formation and downregulated the expressions of Gata4
and Nkx2.5. Mimicking induction of the WNT pathway inhibited Hdac1 expression with upregulated Nkx2.5
expression. WNT3a and WNT3 downregulated the expression of Hdac1, contrary to the effect of SFRP2 and
GSK3β. Cotransfection of β-catenin and Lef1 signiﬁcantly downregulated the expression of Hdac1. Our data
suggest that WNT signaling pathway plays important roles in the regulation of Hdac1 during the early stage
of cardiomyocyte differentiation and that the downregulation of Hdac1 promotes cardiac differentiation.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionEarly cardiomyocyte differentiation involves three stages: the
precardioblast, the cardioblast and the cardiomyocyte stage [1].
Cardiac lineage commitment occurs between the ﬁrst and second
stages upon expression of cardiac transcription factors such as
NKX2.5, GATA4, MEF2C, and dHAND, in which NKX2.5 plays a central
role in both embryo heart development and stem cell cardiomyoge-
nesis [2]. Targeted disruption of murine Nkx2.5 resulted in embryonic
lethality due to arrested looping morphogenesis of the heart tube and
decreased expression of a subset of cardiac muscle-speciﬁc genes [3].
Overexpression of Nkx2.5 can initiate cardiac differentiation in ES cells
aggregated in the absence of DMSO [4]. GATA4, bone morphogenetic
proteins (BMP), ﬁbroblast growth factors (FGF) and theWNT signaling
pathway have all been documented to regulate the expression of
Nkx2.5. However, the precise molecular pathways by which cardiac
regulators act on Nkx2.5 and coordinate cardiac differentiation is still
largely unknown [5].
Epigenetic regulation has recently become important in develop-
ment and differentiation research [6]. At times of genomic repro-).
l rights reserved.gramming, considerable dynamic changes in chromatin architecture,
especially DNAmethylation and histone acetylation, are closely linked
to differentiation and development in mammals [7,8]. Cardiomyoge-
nesis is a complex process associated with dramatic changes in
epigenetic modiﬁcation and regulation of some cardiac genes by
methylation and acetylation [9]. However, methylation levels are
considerably lower in early embryo development and at times of
genomic reprogramming [10]. As DNAmethylation of a gene promoter
represses transcription and recruits other repressive chromatin-
modifying activities, reprogramming might hypomethylate a speciﬁc
gene promoter, initiating gene expression during these stages of
development [11]. This suggests that Nkx2.5, as a CpG island-rich
gene, can potentially be regulated by DNA methylation or histone
acetylation as both modiﬁcations occur together in regulating gene
expression.
Histone acetyl transferases (HATs) and histone deacetylases
(HDACs) loosen or compact chromatin structure, respectively, and
their cooperation establishes and maintains speciﬁc patterns of
histone acetylation for global gene expression [12]. In mammalian
cells there are three classes of HDACs, class I, II and III, in which class I
HDACs comprise HDAC1, 2, 3 and 8 [13]. In addition to regulating
histone acetylation, HDAC1 can itself regulate cell proliferation and
differentiation in embryonic development, as global deletion of Hdac1
in conditional null Hdac1mice resulted in death by embryonic day 9.5.
Table 1
Primers used in RT-PCR and real-time PCR
Primers Primer sequences (5′–3′) Product size(bp)
Hdac1 F: GGGCACCAAGAGGAAAGT 332
R: CTCCCGTGGACAACTGA
Nkx2-5 F: CACCCACGCCTTTCTCAGTC 361
R: CCATCCGTCTCGGCTTTGT
Gata4 F: AAGGTACCTGGACTTTGCCTGTTGGGG 230
R: CTAAGCTTACTGCGGCTGAGCCTCGG
Anf F: CCATCACCCTGGGCTTCT 461
R: TTTCCTCCTTGGCTGTTATCTT
Oct4 F: ATCACTCACATCGCCAATCA 126
R: TGTAGCCTCATACTCTTCTCGTT
Id1 F: CCAGAACCGCAAAGTGAG 200
R: GATCGTCGGCTGGAACAC
18SRNA F: GTAACCCGTTGAACCCCATT 151
R: CCATCCAATCGGTAGTAGCG
Gapdh R: ATCTTCCAGGAGCGAGACC 392
F: CCTTCCACAATGCCAAA
AR1 F: CAGTCTTGGGAGCTCAAGACTAACC 255
R: CAGATCCCCAAGCTTACTAGCAACTAC
AR2 F: CTGCTCATCCATCAGCCAGACGAAGA 357
R: GAAAGATAAGCTGCAACTATCACCCGG
AR3 F: CTGGGTCCTAATGCGGGTGGCGTCTC 246
R: AACCCTCTGCTGTGTGGCCTTGTATCT
Nkx2.5 promoter F:AATGGTACCAGACTGGGTAAGTAGCCTTGA 818
R: TAATTCGAACTGCCTTGTGCTCTGAAA
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in neonatal lethality, accompanied by cardiac arrhythmias, dilated
cardiomyopathy and upregulation of genes encoding skeletal muscle-
speciﬁc contractile proteins and calcium channels [14]. Despite
growing knowledge of the mechanisms of HDAC-dependent regula-
tion in embryo development, very little is known about the role of
HDAC1 in cardiomyogenesis.
The activities of HDACs are tightly controlled and precisely
regulated by multiple mechanisms. The activities of most HDACs are
regulated by protein–protein interactions, post-translational modiﬁ-
cations as well as subcellular localization. Less studied, but perhaps
equally important, is the regulation of some HDACs by control of
transcriptional expression [15], especially in cardiac development. Of
the three most important signaling pathways for cardiomyogenesis
(BMP, FGF andWNT), WNTmay play a role in the regulation of HDAC1
expression. WNT signals exhibit developmental stage-speciﬁc and
biphasic effects on cardiomyogenesis and hematopoiesis [16–18]. One
study, revealing a balance between WNT signaling and HDAC activity
that correlated with the ratio of proliferation to differentiation,
suggested that there is a potential relationship between the WNT/
β-catenin pathway and HDAC1 expression [19]. A complete under-
standing of how HDACs are regulated will contribute not only to our
knowledge of chromatin structure and gene expression control, but
offer useful insight into approaches for developing therapeutic
methods through HDAC modulation. In this study, we used mouse
embryonic carcinoma stem cells, P19CL6 cells, to examine the
mechanism of HDAC1 function and regulation during the differentia-
tion of P19CL6 cells into cardiomyocytes.
2. Materials and methods
2.1. Cell culture and induction of differentiation
P19CL6 cells were cultured as described previously. In brief, the
cells were grown in a 60-mm tissue culture grade dish with marked
grids (Nunclon® Delta, Denmark) under adherent conditions with
α-minimal essential medium (α-MEM, Gibco BRL) supplemented
with 10% fetal bovine serum (FBS, Hyclone USA), penicillin (100 U/ml),
and streptomycin (100 mg/ml) (growth medium) and were main-
tained in a 5% CO2 atmosphere at 37 °C. To induce differentiation
under adherent conditions, P19CL6 cells were plated at a density of
3.7×105 in a 60-mm tissue culture grade dish with the growth
medium containing 1% DMSO (differentiation medium). The medium
was changed every 2 days. Days of differentiation were numbered
consecutively after the ﬁrst day of the DMSO treatment, day 0. The
number of spontaneously beating cells was counted using a DMIL
microscope (Leica, Deerﬁeld, IL) ﬁtted with a grid system. Stable
P19CL6 cell lines expressing Hdac1 were generated using Lipofecta-
mine2000 (Invitrogen). The cells were then plated and grown
in medium under the selection of G418 (400 μg/ml, Sigma). After
2–3 weeks selection, G418 resistant colonies were visible. Five
colonies were isolated for further culture and analysis.
2.2. RT-PCR and real-time RT-PCR
To extract total RNA from P19CL6 cells, Trizol Reagent (Invitrogen)
was used after the cells were washed three times by ice-cold PBS. An
equal amount of total RNA (4 μg) was used for ﬁrst-strand cDNA
synthesis using oligo-dT primer and 0.25 U/μl M-myeloblastosis virus
reverse transcriptase XL (Promega) in a reaction volume of 25 μl
according to the manufacturer's instructions. Synthesized ﬁrst-strand
cDNA (1 μl) was used for each PCR reaction. For RT-PCR, Taq DNA
polymerase (Promega) and GeneAmp PCR System 9700 (Applied
Biosystems) were utilized. The following thermal proﬁle was used for
all PCR experiments: 95 °C for 5 min, and then appropriate cycles at
94 °C for 30 s, annealing temperature (Table 1) for 30 s and 72 °C for30 s, and terminated by a ﬁnal extension at 72 °C for 8 min. The
ampliﬁed PCR products were separated in 2% agarose gel and
visualized under a 302 nm UV light. The ﬁgures shown are
representative of multiple independent experiments (n≥3). The gels
are scanned using Image-Quant software (Kodak 1D V3.53) and semi-
quantitated with Multi Gauge V3.0 (Fujiﬁlm). Each value presents the
average of at least 3 independent experiments. In real-time RT-PCR
experiments, SYBR® Green Real-time Master Mix (TOYOBO) was
utilized. The same thermal proﬁle was used as for RT-PCR, and the PCR
products were subjected to a melting curve analysis and to conven-
tional agarose electrophoresis to exclude synthesis of nonspeciﬁc
products. To quantify each experiment, a Ct valuewas quantiﬁed using
a standard curve for the speciﬁc gene and relatively quantiﬁed using
18s RNA as an internal reference control. Finally, it was normalized to
the average expression levels of the undifferentiated samples, and the
normalized ratios were used to indicate up- and downregulation.
2.3. Western blotting
Total cellular protein and nucleic protein were prepared as
previously described [20]. Protein concentration was determined
using the BCA Protein Assay kit (Pierce). Proteins (30 μg) were
subjected to 10%–12% SDS polyacrylamide gel electrophoresis and
subsequently transferred onto Hybond ECL membranes (Amersham).
After washing with 0.1% TBS-T, membranes were incubated for 1 h at
room temperature in blocking buffer (5% skimmed milk in TBS-T) and
then incubated with appropriate antibodies (1:500 dilution; Histone
H3 histone H4, histone H2b, acetylated histone H3, acetylated histone
H4 and acetylated histone H2b antibodies are from Upstate; HDAC1, 2,
4, 5 antibodies are from SAB; others are from Santa Cruz) overnight at
4 °C. After washing with TBS-T, membranes were reacted with
horseradish-peroxidase-conjugated anti-rabbit antibody (1:2000 dilu-
tion, Santa Cruz) for 2 h at room temperature. After further washing
with TBS-T, detection was performed using ECL Western blotting
detection reagents (Amersham) and Hyperﬁlm ECL (Amersham).
2.4. Luciferase assays
P19CL6 cells were maintained in α-minimal essential medium
supplemented with 10% fetal bovine serum. All transfections were
performed in twelve-well plates using Lipofectamine2000
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amount of DNA was kept constant using pcDNA3.1/β-gal plasmid
DNA. The pRSVluc plasmid (Promega) cotransfected with the LUC
reporter plasmid was used as an internal control. Luciferase activity
was measured in a microplate luminometer (FOLAR star reporter
assay system, BMG), normalized to Renilla luciferase activity. Fold
activation represents a comparison of the ratio of ﬁreﬂy/Renilla
luciferase activity for each condition with that of the reporter vector
control which was arbitrarily set at 1. Each value presented is the
average of triplicate samples and is representative of multiple
independent experiments (n≥3). The data were statistically analyzed
using the unpaired, two-tailed Student's t-test, and differences were
considered signiﬁcant when pb0.05.
2.5. Plasmids construction and transfection
The plasmid construct ANF-luc was a kind gift from Dr. Mona
Nemer (Institut de Recherches Cliniques de Montreal, Montreal).
Nkx2.5 plasmid was obtained from Dr. Ilona S. Skerjanc (University of
Western Ontario, Canada). AR1, AR2 and AR3 active regions were
generated by PCR and cloned into pGEM®-T Easy Vector (Promega) for
sequencing. DNA sequences encoding NKX2.5 N (AAs 1–121), H (AAs
122–202) and C (AAs 203–318) were generated by PCR and cloned into
pGEX 4T-2 or pGEX 5X-1, for the GST pull-down experiment.Wild type
GSK-3β and mutant S9A GSK-3β were kindly provided by Dr. Thilo
Hagen (University of Nottingham, United Kingdom). Id1 plasmid was a
gift from Dr. Peter Lengyel (Department of Molecular Biophysics and
Biochemistry, Yale University). Wnt3, Wnt3a and constitutively active
β-catenin plasmids were kindly provided by Dr. Roel Nusse (Stanford
University School of Medicine). pCG-LEF1-HA plasmid was a kind gift
from Dr. Klaus Wolff (Department of Experimental Dermatology at
the University of Vienna). sFrp2 plasmid was kindly provided by
Dr. Chingjin Chang (Institute of Biological Chemistry, Academia Sinica,
Taiwan). Hdac1 plasmid was a kind gift from Dr. Yongfeng Shang
(Department of Biochemistry and Molecular Biology, Peking Uni-
versity Health Science Centre). Oct4 plasmid was kindly provided by
Dr. Changsheng Lin (Stem Cell Research Centre, Peking University
Health Science Centre).
Gene overexpression and knockdown were carried out generally
by transfection of the plasmids or siRNA using Lipofectamine2000
(Invitrogen) according to the manufacturer's protocol. After 48 h
transfection, the cells were harvest for functional assays. All transfec-
tions were performed at least 3 times.
2.6. Immunoﬂuorescence
Cultured cells on coverslips were induced for 12 days by DMSO and
then ﬁxed with 4% paraformaldehyde for 10min at room temperature.
Following rinsing with PBS, cells were permeabilized with 0.3%
Triton-X 100 (Sigma) for 15 min and then blocked with normal goat
serum for 30 min. In order to detect if cells differentiated into
cardiomyocytes, cells were incubated overnight at 4 °C with primary
antibodies with mouse monoclonal antibodies against α-actinin
(1:200, Sigma). After rinsing with PBS, cells were incubated with
TRITC-conjugated goat anti-mouse IgG (1:200) for 30 min at room
temperature and examined under ﬂuorescence microscopy. Nuclei
were counterstained with Hoechst 33342 (Sigma).
2.7. Flow cytometry analysis
Cell cycle analysis was performed by ﬂow cytometry (FACS). Brieﬂy,
cultured cells were trypsinized into single cell suspensions and ﬁxed
with 70% ethanol for 30 min on ice. RNA was degraded by incubation
with 100 g/ml RNase (Sigma) for 1 h at 37 °C. DNA was labeled with
20 g/ml propidium iodide (PI, Sigma) andDNA contentwas assessed by
FACS Calibur (Becton Dickinson) using the ModiFit LT v2.0 software.2.8. DNA methylation analysis
Genomic DNA was isolated with the Genomic DNA isolation Kit
(Beyotime) and bisulphite treatment was carried out as described
before [11]. Brieﬂy, 2 μg of DNA was diluted into 50 μl with TE buffer
(pH 8.0), then denaturated for 10min at 37 °C with 5.5 μl of 2 M NaOH.
55 μl of freshly prepared hydroxyquinone (10 mM, Sigma) and 520 μl
of freshly prepared sodium bisulphite (40.5%, pH 5, Sigma) were
added, mixed, and incubated under mineral oil at 50 °C for 16 h.
Modiﬁed DNA was puriﬁed using DNA puriﬁcation resin according to
the manufacturer's instruction (Qiagen) and eluted into 100 μl of
water. Modiﬁcation was completed by NaOH treatment (ﬁnal
concentration, 0.3 M) for 10 min at room temperature, followed by
ethanol precipitation. DNA was resuspended in water and used
immediately or stored at −20 °C. Modiﬁed DNA was ampliﬁed with
Platinum® TaqDNA Polymerase (Invitrogen). The PCR fragments
ampliﬁed were gel-puriﬁed and cloned using pGEM-T easy vector
system (Promega). Five clones were sequenced to assess the level of
methylation at each CpG site.
2.9. Chromatin immunoprecipitation (ChIP) assay
ChIP experiments were performed according to the method
described previously [20]. In brief, crude nuclei of induced P19CL6
cells were prepared and the lysates were immunoprecipitated with
nonspeciﬁc rabbit IgG, anti-acetylated-H4 and HDAC1 antibodies for
12 h at 4 °C. Immune complexes were incubated with Protein
A-Sepharose CL-4B (Amersham Biosciences) for 2 h at 4 °C; the
washed immune complexes containing DNAwere then eluted and the
precipitated DNA ampliﬁed by PCR with the primers listed in Table 1.
The products were resolved on 2% gels.
2.10. Immunoprecipitation and GST pull-down assays
Immunoprecipitations were performed according to the manufac-
turer's instructions (Roche). The lysates derived from HeLa cells
cotransfected with Flag-Hdac1 and Nkx2.5 were incubated with anti-
FLAG antibodies (Sigma) or normal IgG for 2 h by a gentle rotation, and
then with 50 μl of protein G-sepharose slurry (Roche) at 4 °C for 1 h.
Immunoprecipitates were washed three times with the lysis buffer
and subjected to SDS-PAGE electrophoresis, then detected with anti-
NKX2.5 (sc-14033, Santa Cruz) antibody. GST-NKX2.5 protein was
coupled to glutathione-Sepharose beads (Pharmacia) and then
incubated with cell lysates extracted from HeLa cells overexpressing
HDAC1 in binding buffer. After four washes with GST binding buffer,
beads were boiled in SDS sample buffer to elute bound protein which
was subsequently resolved by SDS-PAGE electrophoresis and analyzed
by western blotting using anti-HDAC1 antibodies.
2.11. Statistic analysis
The data were expressed as means±S.D. Comparisons between
groups were analyzed by Student's t-test or ANOVA. The signiﬁcance
was analyzed with SPSS10.0 software and a p-valueb0.05 was
considered to be statistic signiﬁcant.
3. Results
3.1. Nkx2.5 gene expression was upregulated during cardiomyogenesis
but no signiﬁcant change in methylation status was observed in the
promoter region
Nkx2.5 was originally identiﬁed as one of the marker genes for
cardiac differentiation. Nkx2.5 gene is ﬁrst expressed in the mouse
embryo at 7.5 dpc (days postcoitum, dpc), reaches a high level of
expression during the whole development process, and maintains a
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regulation of Nkx2.5 gene expression, we analyzed the expression
level of Nkx2.5 during P19CL6 cell differentiation. Semi-quantitative
RT-PCR and real-time RT-PCR analysis with RNA extracted from
P19CL6 cells treated with DMSO showed a gradual increase in Nkx2.5
expressionwith time (Fig. 1A and B). The expression of Gata4, another
cardiac developmental marker gene and a co-activator of Nkx2.5, was
upregulated at the same time; α-MHC, a marker for cardiomyocytes,Fig. 1. The expression of Nkx2.5 increased but activating regions of Nkx2.5 gene underwent no
demonstrating expression of Nkx2.5, Gata4, and α-MHC at days 1, 4, 8 and 12 post-induction
semi-quantitative RT-PCR results (the data represent the average of 3 independent experim
gene structure showing three promoters and one ATG site, and the three CpG island-rich sec
and AR3 (−5870U, −4059D) respectively. (D) 246 bp AR1 (i), 357 bp AR2 (ii) and 255 bp AR3 (
were cloned into the pGL3-basic plasmid respectively for bisulphite sequencing. The position
above the chromatograms. SC: uninduced P19CL6 cells; CC: cardiomyocytes. Methylated
sequencing. (E) The percentage of methylated CpG sites was not signiﬁcantly different betwwas expressed at day 4 after DMSO induction and exhibited an
increase coinciding with the upregulation of Nkx2.5 and Gata4
(Fig. 1A). Subsequently, we examined the relationship between
upregulated Nkx2.5 expression and DNA demethylation in the
promoter region of Nkx2.5. The mouse Nkx2.5 upstream regulatory
region contains multiple enhancers and repressors orchestrating
spatio-temporal expression in distinct populations of cardiomyocytes
during embryonic development. This gene has three transcriptionalsigniﬁcant CpG site methylation change during P19CL6 cells differentiation. (A) RT-PCR
(a representative image of at least 3 experiments). (B) Real-time PCR data conﬁrmed the
ents, each experiment was performed in triplicates, ⁎Pb0.05, #Pb0.01). (C) The Nkx2.5
tions examined of the activating regions, AR1 (−9436U, −7363D), AR2 (−3050U, −1976D)
iii) regions of Nkx2.5 gene in uninduced P19CL6 cells and differentiated cardiomyocytes
s of CpG sites in each region are labeled with a short erect line in the consensus sequence
(solid dot) and unmethylated (hollow dot) CpG sites were determined by bisulphite
een groups (PN0.05 SC versus CC in each AR group; bars represent SD; n=5).
Fig. 2. Total histones and histones at Nkx2.5 promoter underwent hyperacetylation during cardiomyocyte differentiation. (A) Western blotting was performed with total proteins
from P19CL6 cells at different days to detect the acetylation level of histone H2b, histone H3 and histone H4, respectively, and total histones as the control. (B) ChIP assays were
performed with P19CL6 cells at differentiation days 0, 6 and 12. Immunoprecipitated DNA fragments were ampliﬁed by PCR at the promoter regions of Nkx2.5. Input represents 10% of
the total input chromatin. Rabbit preimmune serum (IgG) was used as a negative control. (C) 10 ng/ml TSAwas added to the induced P19CL6 cells at days 0, 6 and 12 for 24 h.Western
blotting was performed to detect the acetylation level of histone H4, using total histone H4 as a control; RT-PCR demonstrated the expression of Nkx2.5, Gapdh as an internal control
(the representative images of above experiments are shown on the left; the semi-quantitative analysis data are shown on the right, representing the average of at least 3 independent
experiments, ⁎Pb0.05, #Pb0.01).
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exons and three introns, more than ﬁve activating regions and three
inhibitory regions, generating three different transcripts in different
tissues and stages during heart development (Fig. 1C) [22]. We
therefore examined the CpG site methylation status of the three most
important CpG island-rich activating regions, AR1 (−9436U, −7363D),
AR2 (−3050U, −1976D) and AR3 (−5870U, −4059D) before and after
induction with DMSO. The PCR products (245 bp, 357 bp and 255 bp)
containing 15, 19 and 17 CpG sites respectively, were inserted into the
pGL3-basic plasmid for bisulphite sequencing (Fig. 1D). To our
surprise, we found that before DMSO induction the percentage of
methylated CpG sites in the AR1 regionwas 28%, compared with 21.3%
after induction (Fig. 1E), a change that was not statistically signiﬁcant.
As for AR2 and AR3, the percentages decreased from 10.5% to 9.47%and from 11.7% to 10.6%, respectively; both were not signiﬁcant
(Fig. 1E). Taken together, the methylation status of these activating
regions underwent no signiﬁcant change in spite of over 80% of
cardiac differentiation of the P19CL6 cells, suggesting that there must
be alternative mechanisms of regulation.
3.2. Histone proteins surrounding the Nkx2.5 promoter were
hyperacetylated during cardiomyogenesis with reduced
expression of Hdac1
To determine whether histone modiﬁcation was involved in
cardiomyogenesis, we examined the overall histone acetylation
level. As shown in Fig. 2A, the degree of acetylated histone H4
(Lys8) as well as acetylated histone H3 (Lys9) gradually increased
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histone H2b (Lys5), a cell cycle-associated protein, displayed no
signiﬁcant change at day 6 and day 12 post-induction compared with
day 0 (Fig. 2A). Our data suggested that P19CL6 cells underwent
extensive acetylation on H3 and H4 histones during cardiomyoge-
nesis, which likely promoted the expression of differentiation-
associated genes.
To determine whether hyperacetylation of histones H3 and H4
occurred on the Nkx2.5 promoter during cardiomyogenesis, we
performed chromatin immunoprecipitation (ChIP) assays at different
days during differentiation. As shown in Fig. 2B, histone H4 (Lys8) and
histone H3 (Lys9) acetylation gradually increased at the Nkx2.5
promoter at day 6 and day 12 of differentiation, whereas the level of
histone H2b (Lys5) acetylation displayed less signiﬁcant changes
during the induction process. It seemed that the upregulation of
Nkx2.5 expression during cardiomyogenesis could be mostly attri-
buted to histone acetylation.
When treated with TSA, a potent histone deacetylase inhibitor, for
24 h at day 0, 6, and 12 of the induction, histone H4 (Lys8) acetylation
as well as Nkx2.5 expression were both increased (Fig. 2C), indicating
that suppression of HDAC enzymatic activity enhances cardiac
differentiation concomitantly with stimulation of cardiac gene
expression. These results further indicate that the upregulation of
Nkx2.5 during cardiomyogenesis is tightly associated with the
selective induction of histone hyperacetylation at the promoter
regions of this gene.
As the degree of histone acetylation is determined by the balance
between HATs and HDACs, to understand the cause of the shift in thisFig. 3. Downregulation of Hdac1 promoted Nkx2.5 expression and histone H4 acetylation. (A
before and in the process of induction, Gapdhwas used as an internal control. (B)Whole-cell l
HDAC2, HDAC4 and HDAC5 respectively, with β-actin as an internal control. (C) Knockdown o
the expressions of Nkx2.5 and Hdac1, with Gapdh as an internal control; Western blotting de
knockdown; Gapdh and histone H4 were used as controls, respectively. (D) RT-PCR demonst
Hdac1 plasmid. (E) ChIP assay detected the recruitment of HDAC1 to the Nkx2.5 promoter.
ampliﬁed by PCR (818 bp product). All the experiments were performed at least 3 times. T
#Pb0.01 versus the controls.balance, we compared the mRNA and/or protein levels of HDAC
isoforms before and after differentiation in P19CL6 cells. Interestingly,
the mRNA level of Hdac1 decreased during the differentiation process
(Fig. 3A), whereas mRNAs of other Hdacs, including Hdac3 and some
class II Hdacs (Hdac5 and 6), were only slightly reduced or unchanged
(data not shown). Accordingly, the protein level of HDAC1 was
markedly decreased during cardiomyogenesis (Fig. 3B), suggesting
that increase of histone acetylation is probably due to decreased
Hdac1 expression. The protein levels of HDACs 2 and 4 exhibited
relatively insigniﬁcant changes in the early stage of differentiation
(day 6 compared to day 0), whereas a marked reduction occurred later
(day 12 compared to day 6, Fig. 3B). No signiﬁcant changes were
observed for HDAC5. We therefore speculate that the histone
acetylation initiated at the early stages of differentiation at least
partly resulted from downregulation of Hdac1 expression. However,
we cannot exclude the participation of other mechanisms, for
example, augmented p300 and the inactivation of class II HDACs via
phosphorylation by CaMK followed by nucleocytoplasmic shuttling
[23].
To further elucidate whether the changes of Hdac1 expression
were associated with cardiac differentiation, we examined the effects
of Hdac1 knockdown using siRNA and overexpression. Knockdown of
Hdac1 expression reduced its protein level by 80% and was
accompanied by enhanced acetylation of histone H4. This led to
increased expression of Nkx2.5 (Fig. 3C). In contrast, overexpression of
Hdac1 led to a decreased level of Nkx2.5 expression (Fig. 3D).
Furthermore, ChIP assay demonstrated that recruitment of HDAC1 to
the Nkx2.5 promoter was decreased during induction (Fig. 3E).) RT-PCR was performed to detect the Hdac1 transcription level (332 bp PCR product)
ysates were subjected toWestern blotting and analyzed using antibodies against HDAC1,
f the Hdac1 gene by 100mM Hdac1-siRNA for 48 h in P19Cl6 cells. RT-PCR demonstrated
monstrated that total HDAC protein and total acetylated histone H4 change after Hdac1
rated the effect of overexpression of Hdac1 on Nkx2.5 expression by transfection of 2 μg
Anti-HDAC1 antibody was used to pull down the chromatin and Nkx2.5 promoter was
he semi-quantitative analysis data represent the average of the experiments, ⁎Pb0.05,
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expression of Nkx2.5 during cardiac differentiation.
3.3. Overexpression of Hdac1 inhibited the P19CL6 cell differentiation
Treatment of aggregated P19 cells with trichostatin A induces the
entry of mesodermal cells into the cardiac muscle lineage, and
overexpression of Hdac4 inhibits cardiomyogenesis [8]. Downregula-
tion of Hdac1 stimulates adipocyte and osteoblast differentiation [24].
Our results indicated that the downregulation of Hdac1 might be
essential for cardiomyogenesis. To directly elucidate whether the
changes in Hdac1 expression were associated with P19CL6 cell
differentiation, we investigated whether Hdac1 overexpression could
affect P19CL6 cell differentiation. Under differentiation conditions,
Hdac1-overexpressing P19CL6 cells displayed inhibited cardiomyo-
genesis (Fig. 4A). The differentiation efﬁciency was less than (50+6)%
in Hdac1-overexpressing cells, compared to (77±9)% in normal
P19CL6 cells (Fig. 4B). This was accompanied by depressed mRNA
levels of Nkx2.5, Gata4 and β-MHC, compared with control cells
(Fig. 4C). In addition, as observed microscopically, nearly all theFig. 4. Overexpression of Hdac1 inhibited P19CL6 cells differentiation. (A) Phase microscopy
transfection of Hdac1 at day 12 during differentiation. Immunostaining was performed with a
(Blue, in nuclei). Scale bar: 50 μm. (B) Differentiation rate of Hdac1 overexpressed P19CL6 ce
were counted randomly in four quadrants of the dish with marked grids (550 grids on
overexpressed P19CL6 group, respectively. ⁎Pb0.05 versus the control group). (C) RT-PCR de
following Hdac1 overexpression, with Gapdh as an internal control (the data represent the
⁎Pb0.05, #Pb0.01, versus Hdac1 untransfected cells.differentiated cardiomyocytes of the control cultures beat synchro-
nously (video S1). In contrast, the Hdac1-overexpressing cells
showed reduced differentiation and irregular uncoordinated bea-
ting (video S2). All these data indicate that overexpression of
Hdac1 indeed depresses expression of cardiac genes and suppress
cardiomyogenesis.
3.4. Canonical Wnt pathway downregulated Hdac1 expression through
β-catenin/LEF1
Subsequently, we wanted to understand the detailed mechanism
underlying the downregulation of Hdac1 expression. Undifferentiated
P19CL6 cells exhibited a high level of Hdac1 expression. The presence
of DMSO may trigger the activation of some signaling pathways,
leading to downregulated Hdac1 expression. Current evidence shows
that WNT, BMP and FGF signaling pathways are key upstream factors
that drive cardiac differentiation. WNT signals exhibit developmental
stage-speciﬁc and biphasic effects on cardiac development. WNT
signals promote cardiomyogenesis, but in the late stages of develop-
ment inhibit cardiomyocyte differentiation [16,17]. Furthermore, it hasand immunoﬂuorescence analysis of P19CL6 cells with (iii, iv) or without (i, ii) stable
n anti-α-actinin monoclonal antibody (Red, in cytoplasm) together with Hoechst33342
lls decreased signiﬁcantly compared with the normal ones. A number of beating ﬁelds
a dish, 96 grids were counted, 3 dishes in normal P19CL6 control group and Hdac1
monstrated the expression of Nkx2.5, Gata4 and β-MHC in P19Cl6 cells during induction
average of 3 independent experiments, each experiment was performed in triplicates.
Fig. 5. Canonical Wnt signaling downregulated HDAC1 expression through the β-catenin/LEF1 pathway. (A) RT-PCR indicated expression of Hdac1 and Nkx2.5 in P19CL6 cells treated
with LiCl at different concentrations for 48 h. (B) Effects ofWnt3a andWnt3 overexpression by plasmids transfection on Hdac1 expression (RT-PCR, Gapdh as an internal control) and
β-catenin nucleic translocation (Western blotting of the nucleic protein, Lamin B as an internal control). (C)Western blotting demonstrated the change of HDAC1 protein and histone
H4 acetylation in P19CL6 cells treated with 50 ng/ml WNT3a peptide for 48 h at day 0 and day 6 during the induction. (D) Semi-quantitative RT-PCR demonstrated the effect of
overexpression of wild type and mutant GSK-3β as well as sFRP2 plasmids on the expression of Hdac1; (E) Real-time RT-PCR indicated the effect of cotransfection of wild type or
mutant β-cateninwith Lef1 on expression of Hdac1. (F) Real-time RT-PCR indicated the bilateral effects of LiCl on expression of Hdac1 at day 0 and day 6 during the differentiation of
P19CL6 cells. All the experiments were performed at least 3 times. The semi-quantitative analysis data represent the average of the experiments, ⁎Pb0.05, #Pb0.01, versus the
controls.
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HDACs could be regulated by the Wnt/β-catenin signaling pathway
[25], implying the possibility of regulation of HDAC1 expression by
WNT signals.
To verify this, we ﬁrst mimicked the activation of WNT signaling
pathways by treating undifferentiated P19CL6 cells with LiCl, and
found that Hdac1 expression was repressed along with increased
expression of Nkx2.5, both in a dose-dependent manner (Fig. 5A).Hdac1 expression was also depressed when overexpressingWnt3 and
Wnt3a, in parallel with an augmented nuclear import of β-catenin
(Fig. 5B). Addition of recombinant WNT3a protein also signiﬁcantly
attenuated Hdac1 expression, accompanied by increased acetylation
of histone H4 at day 0; while reversed effects were observed at day 6
(Fig. 5C).
WNT3a is thought to act via the canonical pathway, ultimately
leading to the accumulation of β-catenin in the nucleus. β-catenin
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expression. LiCl simulates the WNT signaling pathway via liberating
GSK-3β-mediated repression and in turn facilitating the translocation
of β-catenin into the nucleus. As expected, an increase of Hdac1
expression was observed when overexpressing GSK-3β, an antagonist
for the WNT/β-catenin pathway by suppressing β-catenin; the same
effect was observed with the constitutively activated GSK-3β; when
WNT signaling was blocked by overexpression of sFrp2, a competitive
antagonist of WNT receptor ﬁzzled [26], Hdac1 expression was also
signiﬁcantly promoted (Fig. 5D). In addition, β-catenin or Lef1 alone
repressed Hdac1 expression, but there was a signiﬁcant decline in
Hdac1 expression when cotransfected with β-catenin and Lef1
(Fig. 5E), the same effect was seen in combined transfection with
Lef1 and a constitutively activated β-catenin. Therefore, our results
indicate that the activation of GSK-3β contributes to increased Hdac1
expression in undifferentiated cells.
Strikingly, in the late stage of P19CL6 cell differentiation (day 6
of induction) mimicking WNT signaling by treatment with 20 LiCl
led to an increase in the expression of Hdac1 (Fig. 5F). Accordingly,
addition of WNT3a protein at day 6 of differentiation also caused an
increase in Hdac1 expression in parallel with decreased acetylation
level of histone H4 (Fig. 5C). In addition, this biphasic effects
were also observed in the course of differentiation in ES cells
(data not shown). All these data indicate that, at the begin-
ning of cardiac differentiation, WNT signaling represses Hdac1
expression through the β-catenin/LEF1 pathway, but in the lateFig. 6. HDAC1 maintained the self-renewal and undifferentiated phenotype of undifferentiat
The S phase of Hdac1 knockdown P19CL6 cells declined signiﬁcantly versus to normal cells ((
(B) RT-PCR demonstrated the effects of Hdac1 and Hdac1 knockdown to Oct4 and Id1 (#Pb0.0
Oct4 on Hdac expression (⁎Pb0.05, versus the control; n=3).stage it has an opposite effect, coinciding with its biphasic effects on
cardiomyogenesis.
3.5. HDAC1 was essential for maintaining the self-renewal and
undifferentiated phenotype in undifferentiated P19CL6 cells
Why do undifferentiated P19CL6 cells exhibit a high level of Hdac1
expression? A link has been found between HDAC1 and the cell cycle
in cancer cells [27]. We speculated that abundant HDAC1 is required
for proliferation of P19CL6 cells or ES cells. We therefore performed
ﬂow cytometric analysis to detect cell proliferation. Normal P19CL6
cells and Hdac1-knockdown cells showed a marked difference in
proliferation (Fig. 6A). In normal P19CL6 cells, the average percentage
of S phase cells was (43.40±5.02)%, but was only (27.06±4.36)% in the
Hdac1-knockdown cells (pb0.01), suggesting a proliferation-linked
function of HDAC1.
HDAC1 may also be required for maintenance of the undiffe-
rentiated status. We found that overexpression of Hdac1 was
associated with upregulation of Id1, an inhibitory transcription factor
for myogenesis and cardiomyogenesis, which is degraded upon
differentiation. Meanwhile, Hdac1 silencing led to downregulation of
Id1 signiﬁcantly (Fig. 6B). Interestingly, Id1 also exerted similar
positive effect on Hdac1 expression (Fig. 6C). However, HDAC1 did
not seem to have a relationship with OCT4, a transcription factor
that plays an essential role in maintaining pluripotency of cells, as
overexpressing either Hdac1 or Oct4 had no effect each other (Fig. 6C).ed P19CL6 cells. (A) FACS showed the effect of Hdac1 knockdown by siRNA on cell cycle.
27.06±4.36)% versus (43.40±5.02)%, #Pb0.01, n=3, each sample was tested in triplicates).
1 versus the controls, respectively. n=3). (C) RT-PCR demonstrated the effects of Id1 and
Fig. 7. HDAC1 repressed the transcriptional activity of Nkx2.5. (A) pANF-luc represents the rat ANF–638 bp construct upstream from the transcriptional start site. The Nkx2.5 and
Hdac1 plasmids were transfected alone or together with pANF-luc into the P19CL6 cells for 24 h and transcriptional activity detected by Dual-Lucy Assay (⁎Pb0.05 and #Pb0.01, n=3).
(B) Cell lysates were prepared from HeLa cells transfected with 2 μg of FLAG-Hdac1 and Nkx2.5 as indicated. Immunocomplex was precipitated with anti-FLAG or, as control, mouse
nonimmune IgG. The immunoprecipitates were resolved by 12% SDS-PAGE electrophoresis, transferred to a nitrocellulose membrane and probed with anti-NKX2.5 antibody. HC,
heavy chain; LC, light chain. (C) Mapping of the NKX2.5 domains interacting with HDCA1. Bacterially-expressed GST fusion proteins with different fragments of NKX2.5 as indicated,
were bound to GST–sepharose and incubated with nuclear extracts fromHeLa cells overexpressing HDAC1. Material bound to the various GST fusions was analyzed by SDS–PAGE and
Western blotting. N, N-terminal domain; H, homeodomain; C, C-terminal domain of NKX2.5.
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P19CL6 cells is to maintain self-renewal and the undifferentiated
phenotype.
3.6. The transcriptional activity of Nkx2.5 was repressed by HDAC1
It has been reported that HDACs act as transcriptional repressors to
inhibit GATA2, RUNX2, MEF2, PPARγ and other transcriptional factors,
impairing the development of diverse tissues. Both NKX2.2 and
NKX3.2 are able to interact with HDAC1. Thus, we speculated that
there might be a potential interaction between NKX2.5 and HDAC1. To
determine whether Nkx2.5 transcriptional activity is repressed by
HDAC1, we cotransfected Nkx2.5 and Hdac1 into P19CL6 cells and
investigated its transcriptional activation effects on the Anf promoter.
Consistent with a previous report [28], Nkx2.5 alone could active the
Anf promoter by at least 9 folds. However, when cotransfected with
Hdac1, the activation decreased signiﬁcantly (Fig. 7A). In addition, we
examined the interaction between HDAC1 and NKX2.5 by GST pull-
down and Co-IP assay. Interestingly, HDAC1 physically associated with
NKX2.5 mainly via its homeodomain and partly via its N-terminal
region (Fig. 7B and C). These results indicate that HDAC1 is able to
repress the transcriptional activity of NKX2.5 via direct interaction.
4. Discussion
NKX2.5 is a crucial regulator of cardiomyogenesis, regulating
expression of a number of cardiac-speciﬁc genes. Nkx2.5 is expressed
in early cardiac progenitor cells prior to cardiomyogenesis and
throughout adulthood [29]. Epigenetic changes of the Nkx2.5
promoter were thought to contribute to the spatial and temporalpatterns of Nkx2.5 expression through DNA demethylation and post-
translational histone modiﬁcations. The present study was performed
to examine the effect and exact mechanism of DNA methylation and
histone acetylation on the Nkx2.5 promoter during P19CL6 cell
differentiation into cardiac myocytes.
Sequential events of demethylation and de novo methylation are
believed to occur during differentiation. It is well documented that
there are correlations between the DNA methylation status of OCT4
and the differentiation status of embryonic cells [30]. Strikingly,
though a marked augmentation of Nkx2.5 expression occurred during
cardiomyogenesis, we did not detect signiﬁcant alteration of
demethylation in associated CpG islands of three DNA segments
located in the Nkx2.5 promoter. In undifferentiated P19CL6 cells (low
level expression of Nkx2.5) and ES cells (no expression), the Nkx2.5
promoter exhibited a hypomethylated status, at least in detected CpG
islands, to a similar extent as in differentiated cardiomyocytes.
Therefore, the potential role of DNA demethylation in the control of
Nkx2.5 expression in a tissue- and time-speciﬁc manner remains in
question. Likewise, the CpG islands in the muscle determination gene
MyoDwere not methylated in nonexpressing tissues such as the brain
[31]. Previous documents indicated that different genes may possess
variable and specialized DNA modiﬁcation patterns. Nevertheless, we
have not excluded the possibility that P19CL6 cells, as committed
embryonic carcinoma cells, have undergone a demethylation event
leading to activation of the Nkx2.5 promoter.
In contrast, histone modiﬁcations, notably acetylation and deace-
tylation, appear to be crucial for the regulation of Nkx2.5 expression at
the transcriptional level. Our results demonstrate that histone
proteins on the Nkx2.5 promoter were gradually hyperacetylated
during DMSO-induced differentiation, in parallel with a dramatic
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enhanced cardiomyogenesis and cardiac marker gene expression,
suggesting that prevention of endogenous HDAC enzymatic activity is
important for the execution of the cardiomyogenic program. In
differentiated P19CL6 cells, total HDAC enzymatic activity was
signiﬁcantly decreased, accompanied by an increase of hyperacetyla-
tion of histones H3 and H4. It seems that histone acetylation spreads
over broad genomic areas resulting in large regional effects rather
than affecting Nkx2.5 expression alone. The downregulation of total
HDAC enzymatic activity during cardiomyogenesis is probably due to
decreased Hdac1 expression. Using ChIP, we found that recruitment of
HDAC1 to Nkx2.5 promoter regions was markedly reduced after DMSO
treatment. Overexpression of Hdac1 attenuated cardiomyogenesis
and Nkx2.5 expression whereas knockdown of Hdac1 by RNAi
promoted cardiomyogenesis with an accompanying increase in
Nkx2.5 expression. Although, we could not establish the relationship
between the HDAC1 and differentiation rate of P19CL16, the expres-
sion and recruitment Hdac1 correlated well with the expression of
cardiac-speciﬁc gene Nkx2.5 (Figs. 3A, E and 1A, B). Taken together,
our results suggest that HDAC1 is a critical factor regulating Nkx2.5
expression in a deﬁned manner during cardiomyogenesis.
Covalent modiﬁcations of the histone tails regulated by HATs and
HDACs have been proposed to act as epigenetic marks that impart
transient or permanent “cellular memory” of the transcriptional
activation state of speciﬁc genes [32]. HATs facilitate chromatin
opening by acetylating the N-terminal tails of nucleosomal histones,
thus promoting active transcription. Conversely, HDACs deacetylate
lysine residues and induce compaction of chromatin, making the
access of transcription factors to nearby promoters more difﬁcult and
thereby resulting in gene silencing. As coregulators, HDACs have
been recently implicated in coordinating the activation and repres-
sion of genes involved in the differentiation process. For instance,
Hdac1 knockdown promoted adipogenesis whereas Hdac1 over-
expression attenuated adipocyte differentiation in 3T3-L1 cells.
Furthermore, HDAC1 and members of the class II HDACs inhibit
MyoD and Mef2, respectively, blocking myogenesis. In addition, it
has been reported that HDAC1 and HDAC3 physically interact
with RUNX2 and suppress its transcriptional activity in osteoblast
differentiation.
Class II HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) have been
shown to interact with MEF2C and SRF, and overexpression of Hdac4
inhibits cardiomyogenesis, as shown by the downregulation of cardiac
muscle gene expression. Furthermore, most Hdac5-Hdac9 double
knockout mice died owing to heart defects, suggesting a role for class
II HDACs in heart development [33]. TSA added to aggregated ES cells
at a later stage (day 7) promoted differentiation by activating GATA4
by acetylation. It has been reported that TSA alone is sufﬁcient to
induce cardiomyogenesis in the absence of DMSO [8]. Our results
provide further evidences that a member of class I HDACs, HDAC1, is a
repressor of cardiomyogenesis.
Individual HDACs may play differential roles in developmental
stages of cardiamyocytes. In terminally differentiated cardiomyocytes,
the class II HDACs repressed the pro-hypertrophic gene program,
whereas class I HDACs seemed to suppress anti-hypertrophic gene
expression. TSA treatment consistently inhibited hypertrophic growth
of post-mitotic cardiomyocytes and reactivation of fetal genes such as
ANF. Thus, more studies are required to investigate the underlying
reasons why HDAC1 exhibits biphasic effects on ANF expression at
different developmental stages.
Though class II HDACs exerted a repressive effect on cardiomyo-
genesis, post-translational modiﬁcation could override the repres-
sion. Treatment with DMSO increased intracellular Ca2+, thereby
activating CaMK [34]. Class II HDACs phosphorylated by CaMK
shuttled from the nucleus to the cytoplasm, activating MEF2C and
other transcriptional activators. However, class I HDACs did not
contain the phosphorylation sites that are conserved and exclusivelylocated in the N-terminals of HDACs 4/5/7/9 [15]. Importantly, we
observed that the expression of Hdac1 was decreased during
cardiomyogenesis; its transcriptional downregulation reduced its
inhibitory effect. Subsequent experiments demonstrated that the
WNT signaling pathway may contribute to the downregulation of
Hdac1. Overexpression of Wnt3a or combined transfection with Lef1
and β-catenin also evoked the decrease of Hdac1 mRNA, whereas
SFRP2 upregulated the expression of Hdac1. Early stage treatment
with LiCl, which binds and inhibits GSK-3β and then activates WNT
signaling selectively via the β-catenin/LEF1 pathway, also triggered a
dramatic inhibition of Hdac1 expression. Strikingly, addition of LiCl
upregulated the expression of Hdac1 and inhibit Nkx2.5 expression.
Previous reports have provided substantial evidence to demonstrate
that WNT/β-catenin signaling promotes cardiac differentiation at
early developmental stages and inhibited it at later stages. Except for
the ﬁnding that WNT3a inhibited BMP2/4 expression at the late
stages of differentiation, other associated mechanisms in relation to
the antagonistic effects of WNT signaling on cardiomyogenesis still
remained obscure. Based on our data, we present a hypothesis that
the biphasic effect of WNT/β-catenin signaling could function via
modulation of Hdac1 expression. Taken together, we, for the ﬁrst
time, provide a possible mechanism through which the WNT/
β-catenin/GSK-3β signaling pathway accelerates cardiomyogenesis
by downregulating Hdac1 expression at an early stage of cardiomyo-
genic differentiation.
We also noticed that the Hdac1 alone could activate the ANF
promoter signiﬁcantly, but the mechanism is still unclear. Previous
reports demonstrated that inhibition of HDACs could block myocar-
diac hypertrophy [35,36], in which the ANF played important roles.
We propose that the HDACs may have some direct or indirect effects
on ANF.
In addition, we also observed that overexpression of Hdac1 in
undifferentiated P19CL6 resulted in a signiﬁcant augmentation of Id1
expression, a transcriptional repressor blocking myogenesis and
cardiomyogenesis by binding to MyoD, GATA4 and NKX2.5 and
inhibiting their binding to DNA [37]. Oct4 expression was unaffected.
Further investigation indicated that there existed a reinforcing
regulatory loop for Id1 and Hdac1 to upregulate expression of each
other. Combined with the evidence that knockdown of Hdac1 induced
G1 cell cycle arrest, our data indicates that HDAC1 is important for
stem cells to maintain the self-renewal and undifferentiated
phenotype.
Previous research revealed that a direct interaction existed
between p300 and NKX2.5 [38]. The homeodomains of NKX2.2 and
NKX3.2 have been suggested to mediate the direct interaction with
HDAC1 [39]. In this study, we have found that HDAC1 can interact with
NKX2.5 and repress its transcriptional activity. This result implies that
NKX2.5 may mediate the recruitment of HDAC1 to repress certain
target genes in the absence of induction signals. It is feasible to
postulate that NKX2.5 may switch its coregulator(s) from HDAC1 to
p300 upon differentiation signals, leading to hyperacetylation of
histone proteins at the promoters of cardiac genes as well as ANF
during cardiomyogenesis. Together, we have provided more informa-
tion about the complexity and pleiotropism of HDAC1 modulating
cardiomyogenesis.
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